Bio-Rad Laboratories (BIO) Short Interest Ratio & Short Volume $320.31 -29.92 (-8.54%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Bio-Rad Laboratories Short Interest DataBio-Rad Laboratories (BIO) has a short interest of 651,700 shares, representing 3.40% of the float (the number of shares available for trading by the public). This marks a -20.82% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 246,199 shares to cover all short positions.Current Short Interest651,700 sharesPrevious Short Interest823,100 sharesChange Vs. Previous Month-20.82%Dollar Volume Sold Short$233.43 millionShort Interest Ratio2.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares27,997,000 sharesFloat Size19,150,000 sharesShort Percent of Float3.40%Today's Trading Volume286,588 sharesAverage Trading Volume246,199 sharesToday's Volume Vs. Average116% Short Selling Bio-Rad Laboratories? Sign up to receive the latest short interest report for Bio-Rad Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIO Short Interest Over TimeBIO Days to Cover Over TimeBIO Percentage of Float Shorted Over Time Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Bio-Rad Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024651,700 shares $233.43 million -20.8%3.4%2.2 $358.19 10/15/2024823,100 shares $281.63 million -3.3%4.3%2.8 $342.16 9/30/2024851,300 shares $285.10 million -36.9%4.5%2.7 $334.90 9/15/20241,350,000 shares $440.40 million +28.6%7.1%4 $326.22 8/31/20241,050,000 shares $354.19 million +11.7%5.5%4 $337.32 8/15/2024940,000 shares $306.41 million -26.0%4.9%3.7 $325.97 Get the Latest News and Ratings for BIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,270,000 shares $429.84 million -10.6%6.6%4.9 $338.46 7/15/20241,420,000 shares $429.00 million +10.9%7.2%5.6 $302.11 6/30/20241,280,000 shares $349.58 million +47.6%6.5%5.1 $273.11 6/15/2024867,500 shares $244.86 million +15.3%4.4%3.6 $282.26 5/31/2024752,200 shares $215.78 million +15.1%3.8%3.7 $286.86 5/15/2024653,400 shares $196.65 million -10.9%3.3%3.2 $300.97 4/30/2024733,100 shares $197.75 million +6.5%3.7%3.4 $269.75 4/15/2024688,500 shares $206.83 million +21.9%3.5%3.3 $300.41 3/31/2024564,800 shares $195.35 million -2.5%2.9%2.8 $345.87 3/15/2024579,300 shares $193.20 million +15.1%2.9%2.9 $333.51 2/29/2024503,400 shares $164.05 million -14.3%2.5%2.2 $325.88 2/15/2024587,100 shares $193.18 million +11.5%3.0%2.5 $329.04 1/31/2024526,700 shares $169.01 million +1.0%2.6%2 $320.89 1/15/2024521,300 shares $166.07 million +15.0%2.6%1.8 $318.56 12/31/2023453,400 shares $146.40 million -9.9%2.2%1.6 $322.89 12/15/2023503,300 shares $154.07 million -22.5%2.5%1.8 $306.12 11/30/2023649,300 shares $198.13 million +13.5%3.2%2.6 $305.14 11/15/2023572,100 shares $175.57 million +36.9%2.8%2.4 $306.89 10/31/2023418,000 shares $115.06 million +23.9%2.0%2.1 $275.27 10/15/2023337,300 shares $116.28 million +1.8%1.7%1.8 $344.73 9/30/2023331,500 shares $118.83 million -14.7%1.6%1.9 $358.45 9/15/2023388,500 shares $146.17 million -10.7%1.9%2.1 $376.23 8/31/2023435,100 shares $174.13 million +6.3%2.1%2.2 $400.20 8/15/2023409,500 shares $161.70 million +21.8%2.0%1.9 $394.88 7/31/2023336,300 shares $136.30 million +1.1%1.6%1.3 $405.28 7/15/2023332,800 shares $131.98 million +17.6%1.6%1.5 $396.57 6/30/2023283,100 shares $107.27 million +0.6%1.4%1.4 $378.90 6/15/2023281,400 shares $106.67 million -26.7%1.3%1.4 $379.06 5/31/2023383,800 shares $143.29 million +31.8%1.8%2 $373.35 5/15/2023291,200 shares $111.17 million +23.2%1.4%1.5 $381.75 4/30/2023236,400 shares $106.57 million -13.9%1.1%1.3 $450.79 4/15/2023274,400 shares $131.51 million +3.5%1.3%1.7 $479.25 3/31/2023265,200 shares $127.04 million -26.8%1.3%1.6 $479.02 3/15/2023362,400 shares $173.23 million +29.9%1.7%2.2 $478.00JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/28/2023279,000 shares $133.32 million +13.8%1.3%1.7 $477.84 2/15/2023245,100 shares $112.87 million -1.9%1.2%1.5 $460.52 1/31/2023249,900 shares $116.82 million -10.1%1.2%1.4 $467.46 1/15/2023278,100 shares $126.59 million +10.1%1.3%1.3 $455.20 12/30/2022252,500 shares $106.17 million +8.8%1.2%1.1 $420.49 12/15/2022232,100 shares $97.59 million +17.2%1.1%0.9 $420.48 11/30/2022198,100 shares $82.15 million -30.3%0.9%0.8 $414.71 11/15/2022284,100 shares $119.64 million +12.7%1.3%1.2 $421.11 10/31/2022252,000 shares $88.63 million +1.3%1.2%1.2 $351.71 10/15/2022248,800 shares $98.20 million -17.7%1.2%1.4 $394.71 9/30/2022302,400 shares $126.14 million -20.1%1.4%1.9 $417.14 9/15/2022378,400 shares $178.89 million +2.9%1.8%2.6 $472.75 8/31/2022367,600 shares $178.30 million +24.0%1.7%2.5 $485.04 8/15/2022296,500 shares $162.04 million -11.6%1.4%1.8 $546.52 7/31/2022335,400 shares $188.92 million -0.8%1.6%1.8 $563.26 7/15/2022338,100 shares $167.03 million -13.0%1.6%1.7 $494.04 6/30/2022388,600 shares $192.36 million -6.3%1.8%1.8 $495.00 6/15/2022414,700 shares $199.24 million -26.4%2.0%1.9 $480.44 5/31/2022563,300 shares $302.94 million +38.1%2.6%2.6 $537.79 5/15/2022408,000 shares $204.86 million +22.6%1.9%1.8 $502.11 4/30/2022332,800 shares $170.41 million +0.8%1.6%1.4 $512.06 4/15/2022330,200 shares $181.01 million +3.5%1.6%1.4 $548.19 3/31/2022319,100 shares $179.73 million +7.2%1.5%1.4 $563.23 3/15/2022297,700 shares $163.36 million -5.1%1.4%1.4 $548.74 2/28/2022313,600 shares $196.30 million +3.0%1.5%1.5 $625.96 2/15/2022304,500 shares $188.09 million +10.1%1.4%1.6 $617.69 1/31/2022276,600 shares $165.89 million -8.0%1.3%1.8 $599.73 1/15/2022300,700 shares $188.91 million -0.2%1.4%2.3 $628.23 12/31/2021301,400 shares $227.73 million -7.3%1.4%2.7 $755.57 12/15/2021325,100 shares $241.99 million -13.7%1.5%2.9 $744.35 11/30/2021376,600 shares $283.66 million -5.5%1.8%3.3 $753.20 11/15/2021398,400 shares $300.33 million -1.7%1.9%3.4 $753.84 10/29/2021405,100 shares $321.92 million -6.1%1.9%3.4 $794.68 10/15/2021431,600 shares $311.39 million -8.0%2.0%3.6 $721.48 9/30/2021469,200 shares $350.00 million -6.1%2.2%3.9 $745.95 9/15/2021499,600 shares $394.72 million -6.3%2.4%4.1 $790.08 8/31/2021533,000 shares $428.97 million -20.3%2.5%4.7 $804.82 8/13/2021668,400 shares $520.22 million +3.6%3.2%5.6 $778.30 7/30/2021645,100 shares $477.06 million +7.0%3.1%5.3 $739.51 7/15/2021602,800 shares $401.93 million +9.5%2.8%4.8 $666.77 6/30/2021550,400 shares $354.62 million -0.2%2.6%4.2 $644.29 6/15/2021551,200 shares $335.83 million -0.1%2.6%4.2 $609.27 5/28/2021551,800 shares $332.39 million +5.8%2.6%3.8 $602.37 5/14/2021521,400 shares $308.13 million -8.8%2.5%3.4 $590.97 4/30/2021571,900 shares $366.43 million -3.6%2.7%3.1 $640.73 4/15/2021593,000 shares $362.98 million +10.0%2.8%3.1 $612.11 3/31/2021539,100 shares $304.13 million -2.9%2.5%2.5 $564.15 3/15/2021555,000 shares $310.79 million -19.0%2.6%2.4 $559.98 2/26/2021685,300 shares $399.15 million +11.0%3.2%2.9 $582.45 2/12/2021617,400 shares $397.49 million +11.9%2.9%2.4 $643.81JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/29/2021551,800 shares $312.56 million -10.5%2.6%2.3 $566.44 1/15/2021616,200 shares $365.49 million -3.4%2.9%2.7 $593.14 12/31/2020637,700 shares $366.57 million +21.7%3.0%3 $574.83 12/15/2020523,800 shares $303.62 million -2.0%2.5%2.5 $579.65 11/30/2020534,400 shares $285.94 million +37.9%2.5%2.7 $535.07 11/15/2020387,600 shares $233.47 million -6.3%1.8%2.3 $602.36 10/30/2020413,700 shares $234.99 million -8.0%2.0%2.5 $568.03 10/15/2020449,600 shares $250.60 million +24.9%2.1%2.9 $557.39 9/30/2020360,000 shares $185.57 million -31.1%1.7%2.1 $515.46 9/15/2020522,600 shares $268.00 million -6.3%2.5%2.7 $512.82 8/31/2020557,700 shares $283.64 million +10.9%2.7%2.2 $508.59 8/14/2020502,800 shares $254.60 million -1.0%2.4%1.9 $506.37 7/31/2020508,100 shares $266.70 million -11.9%2.4%1.9 $524.89 7/15/2020576,400 shares $281.84 million -0.7%2.8%2 $488.96 6/30/2020580,400 shares $250.93 million +29.0%2.8%1.9 $432.34 6/15/2020449,900 shares $204.20 million +0.7%2.1%1.5 $453.88 5/29/2020446,700 shares $219.47 million -10.1%2.1%1.7 $491.32 5/15/2020496,900 shares $227.46 million -15.7%2.4%1.9 $457.76 4/30/2020589,600 shares $259.48 million -2.1%2.8%2.3 $440.10 4/15/2020602,500 shares $244.36 million +10.4%2.8%2.6 $405.58 3/31/2020545,800 shares $236.34 million -17.8%2.6%2.4 $433.01 3/13/2020664,100 shares $261.08 million +5.3%3.1%3.3 $393.14 2/28/2020630,500 shares $205.76 million +37.6%3.0%3.1 $326.34 2/14/2020458,300 shares $168.47 million +0.7%2.2%2.2 $367.59 1/31/2020455,000 shares $167.90 million -20.8%2.1%2.2 $369.00 1/15/2020574,500 shares $213.42 million +0.6%2.7%2.6 $371.48 12/31/2019570,900 shares $211.22 million +8.9%2.7%2.5 $369.97 BIO Short Interest - Frequently Asked Questions What is Bio-Rad Laboratories' current short interest? Short interest is the volume of Bio-Rad Laboratories shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 651,700 shares of BIO short. 3.40% of Bio-Rad Laboratories' shares are currently sold short. Learn More on Bio-Rad Laboratories' current short interest. What is a good short interest ratio for Bio-Rad Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIO shares currently have a short interest ratio of 2.0. Learn More on Bio-Rad Laboratories's short interest ratio. Which institutional investors are shorting Bio-Rad Laboratories? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bio-Rad Laboratories: Jane Street Group LLC, Wolverine Trading LLC, Walleye Capital LLC, Concourse Financial Group Securities Inc., and Cubist Systematic Strategies LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bio-Rad Laboratories? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.40% of Bio-Rad Laboratories' floating shares are currently sold short. Is Bio-Rad Laboratories' short interest increasing or decreasing? Bio-Rad Laboratories saw a decrease in short interest in the month of October. As of October 31st, there was short interest totaling 651,700 shares, a decrease of 20.8% from the previous total of 823,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bio-Rad Laboratories' float size? Bio-Rad Laboratories currently has issued a total of 27,997,000 shares. Some of Bio-Rad Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bio-Rad Laboratories currently has a public float of 19,150,000 shares. How does Bio-Rad Laboratories' short interest compare to its competitors? 3.40% of Bio-Rad Laboratories' shares are currently sold short. Here is how the short interest of companies compare to Bio-Rad Laboratories: Agilent Technologies, Inc. (1.21%), Mettler-Toledo International Inc. (1.34%), Illumina, Inc. (4.24%), Waters Co. (3.63%), Bio-Techne Co. (2.00%), Charles River Laboratories International, Inc. (3.62%), Bruker Co. (3.70%), Pacific Biosciences of California, Inc. (18.41%), Harvard Bioscience, Inc. (0.91%), Thermo Fisher Scientific Inc. (0.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Bio-Rad Laboratories stock? Short selling BIO is an investing strategy that aims to generate trading profit from Bio-Rad Laboratories as its price is falling. BIO shares are trading down $29.92 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bio-Rad Laboratories? A short squeeze for Bio-Rad Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIO, which in turn drives the price of the stock up even further. How often is Bio-Rad Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIO, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies A Short Interest Data MTD Short Interest Data ILMN Short Interest Data WAT Short Interest Data TECH Short Interest Data CRL Short Interest Data BRKR Short Interest Data PACB Short Interest Data HBIO Short Interest Data TMO Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:BIO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO Stock Alerts